🇺🇸 transamin in United States

862 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 136 reports (15.78%)
  2. Platelet Count Decreased — 111 reports (12.88%)
  3. Pneumonia — 110 reports (12.76%)
  4. Diarrhoea — 85 reports (9.86%)
  5. Interstitial Lung Disease — 80 reports (9.28%)
  6. Anaemia — 78 reports (9.05%)
  7. Hepatic Function Abnormal — 68 reports (7.89%)
  8. Nausea — 67 reports (7.77%)
  9. Alanine Aminotransferase Increased — 65 reports (7.54%)
  10. Aspartate Aminotransferase Increased — 62 reports (7.19%)

Source database →

Other Rare Disease approved in United States

Frequently asked questions

Is transamin approved in United States?

transamin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for transamin in United States?

Erzincan Military Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.